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Bartonella DNA in 
Loggerhead Sea 
Turtles 
To the Editor: Bartonella are fas-
tidious, aerobic, gram-negative, facul-
tative, intracellular bacteria that infect 
erythrocytes, erythroblasts, endothelial 
cells, monocytes, and dendritic cells, 
and are transmitted by arthropod vec-
tors or by animal scratches or bites (1–
6). Currently, 20 species or subspecies 
of Bartonella have been characterized, 
of which 8 are known zoonotic patho-
gens (7). B. henselae has been recently 
identiﬁ  ed from canine blood (8) and 
from harbor porpoises (9). Pathogenic 
bacteria are an important threat in ter-
restrial and marine environments, and 
in the case of B. henselae, reservoir 
hosts may be more diverse than cur-
rently recognized. 
The purpose of this study was 
to determine whether sea turtles are 
infected with Bartonella spp. Blood 
samples were obtained from 29 free-
ranging and 8 captive, rehabilitating 
loggerhead sea turtles (Caretta caret-
ta) from North Carolina coastal wa-
ters. Reptilian erythrocytes are nucle-
ated, and commercial lysis methods 
clogged ﬁ  ltration columns because of 
the high DNA content of whole blood. 
Consequently, DNA was extracted 
from frozen whole blood by using a 
modiﬁ  ed alkaline lysis method adapt-
ed from an avian cell culture DNA ex-
traction method (10). PCR screening 
for Bartonella was performed by using 
primers for the 16S-23S internal tran-
scribed spacer (ITS) region (Table). 
Bartonella ITS–positive samples were 
further screened by using primers for a 
consensus sequence of the phage-asso-
ciated gene Pap31 (9). Primers for the 
28S rRNA were used as a housekeep-
ing gene. The PCR-positive control 
contained 0.002 pg/μL of B. hense-
lae H1. Water was the negative PCR 
control. Amplicons of the expected 
sizes were consistently obtained from 
housekeeping gene and positive con-
trol reactions, while amplicons were 
never obtained from negative controls. 
ITS amplicons were obtained from 16 
(43%) of 37 sea turtle blood samples 
tested, including samples from 13 
free-ranging and 3 rehabilitated turtles. 
Pap31 PCR was performed for Bar-
tonella ITS-PCR–positive samples. 
Pap31 amplicons were obtained from 
5 samples of which 3 were success-
fully sequenced. Ampliﬁ  cation  and 
sequencing of the 16S-23S ITS region 
detected 2 Bartonella species: a B. 
henselae–like organisms and 1 more 
similar to B. vinsonii subsp. berkhofﬁ  i. 
The 3 Pap31 amplicons successfully 
sequenced conﬁ  rmed B. henselae in-
fection. Sequences obtained from 1 
sample matched B. henselae strains 
H1-like, the B. henselae SA2-like 
strain, and B. vinsonii subsp. berkhof-
ﬁ  i genotypes II and IV, which sug-
gests that this turtle was co-infected 
with multiple Bartonella spp. and 
strains. Three other samples yielded 
amplicons 99%–100% identical with 
B. henselae strain SA2, and 3 yielded 
sequences most similar to B. vinsonii 
subspecies berkhofﬁ  i genotypes II and 
IV. Two samples contained an ITS 
region sequence most similar to B. 
henselae SA2, but with a 15-bp dele-
tion beginning 617 bases downstream 
from the 16S rRNA gene. Whether 
these ITS sequence differences rep-
resent distinct strains or nonrandom 
translocation events is uncertain.
Four sea turtle blood samples 
contained partial ITS sequences most 
similar to B. vinsonii subsp. berkhofﬁ  i. 
However these amplicons were much 
shorter than expected for B. vinsonii 
subspecies berkhofﬁ  i genotype II and 
genotype IV sequences in GenBank. 
Because Pap31 gene ampliﬁ  cation 
was unsuccessful for these samples, 
it is unclear whether small amplicons 
represent a species related to B. vin-
sonii subsp. berkhofﬁ  i or a new Bar-
tonella sp.
Table. Primers used for PCR amplification 
Primer Sequence
28s s  5′-AAACTCTGGTGGAGGTCCGT-3′
28s as  5′-CTTACCAAAAGTGGCCCACTA-3′
ITS 325s  5′-CTTCAGATGATGATCCCAAGCCTTTTGGG-3′
ITS 1100as  5′-GAACCGACGACCCCCTGCTTGCAAAGCA-3′
Pap 31 1s  5′-ACTTCTGTTATCGCTTTGATTTCRRCT-3′
Pap 31 688(as)  5′-CACCACCAGCAAAATAAGGCAT-3′LETTERS
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To our knowledge, detection of 
Bartonella spp. DNA in sea turtle 
blood represents the ﬁ  rst  molecular 
evidence of Bartonella infection in 
nonmammalian vertebrates. B. hense-
lae infection, now reported in porpois-
es and sea turtles, may represent an 
emerging infection of marine animals. 
According to previous studies, im-
mune status appears to affect disease 
severity, variation in clinical manifes-
tations, the pattern of histopathologic 
features, and the relative ease of diag-
nostic detection of the organism (4,7). 
Although healthy at the time of sample 
collection, the captive rehabilitated sea 
turtles were known to have been sick 
or injured before sampling, poten-
tially reﬂ  ecting immunocompromise. 
Whether detection of Bartonella spp. 
in blood of sea turtles is a function of 
prior immunosuppression induced by 
stressors is not known. Such stressors 
could include mechanical injury, mal-
nutrition, environmental toxins, para-
sites, or concurrent bacterial or viral 
infections. Alternatively, sea turtles 
may be a natural marine reservoir for 
B. henselae or for a Bartonella sp. ge-
netically related to B. vinsonii subsp. 
berkhofﬁ  i. 
In summary, documentation of B. 
henselae and an organism genetically 
similar to B. vinsonii subsp. berkhofﬁ  i 
in the blood of loggerhead sea turtles 
provides evidence that this genus is 
not ecologically limited to terrestrial 
reservoirs. The geographic distribu-
tion, prevalence of infection, carrier 
potential, mode of transmission, and 
pathogenicity of bloodborne Barton-
ella spp. in sea turtles await additional 
studies.
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Human Oestrus sp. 
Infection, Canary 
Islands
To the Editor: Myiasis due to 
Oestrus ovis is a well known zoonosis 
that affects a variety of animals. Hu-
man myiasis has also been described 
and affects mainly persons in rural 
areas such as shepherds (1) and farm-
ers (2). Although this disease has been 
reported in both humans and mam-
mals in Spain (3,4), no human case 
has been described on the Canary Is-
lands. We describe what we believe is 
the ﬁ  rst conﬁ  rmed case on the islands 
and discuss the potential utility of se-
rologic diagnosis for this disease. 
A 55-year-old farmer from the is-
land of El Hierro, with a medical his-
tory of hypercholesterolemia, Q fever, 
and murine typhus, but currently not 
being treated, consulted a physician in 
August 2005 concerning a wormlike 
sensation in his nose and sinuses that 
had lasted 2 days. Three days before 
noticing this sensation, he had been 
working in his neighbor’s barn, when 
he noticed that a passing ﬂ  y “dropped” 
something in his nose. He also reported 
sneezing and watery rhinorrhea. These 
symptoms were self-treated with nasal 
anticongestants, which provided tem-
porary relief. He ﬁ  nally sought medi-
cal attention when a severe cough de-